If you hold — or want — an NMPA registration for a medical device, these are the routes available and what each one requires of you.
Three regulatory routes exist for bringing an overseas device into China. Which one fits depends mainly on whether your product already holds an NMPA import registration certificate.
The registrant always holds the registration certificate. The platform holds the manufacturing licence and bears the corresponding manufacturing responsibility — we never hold the certificate for your product.
One cross-border localization project is currently in execution — dental imaging equipment for a registrant based in South Korea, moving through localized design and manufacturing toward registration testing. Four further projects are in the pipeline for registrants based in Canada, the United States and the United Kingdom, and have not yet commenced. Full detail by category and pathway is on the Delivered Work page.
Human-derived samples. If your project involves human tissue or cells — including organoid-based evaluation — China's human genetic resources regulations apply to foreign-party participation, and approval or filing requirements must be assessed before work begins. Raise this with us at scoping stage.
Nonclinical safety data. Where your submission requires GLP-accredited nonclinical data, we will tell you at scoping stage how that work is sourced rather than leaving it implied.
Overseas registrant enquiries are handled by Ms. Vincy Mo. Send the device classification and intended use and we will come back with the applicable route and what it requires.